Short answer
SBC Medical Group Holdings Inc (SBC) filed an 8-K current report with the SEC on July 14, 2026 reporting Item 3.01 (Notice of Delisting), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Nasdaq noncompliance triggered by Mike Sayama’s departure from the Board and Audit Committee.
- This filing includes Item 3.01, an item that often signal trouble.
SBC Medical Group Holdings Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Nasdaq noncompliance triggered by Mike Sayama’s departure from the Board and Audit Committee
- Board now four members, with two independent directors; Audit Committee has two independent members
- Nasdaq cure period runs until the earlier of the next annual meeting or July 9, 2027
- Earlier annual meeting requires compliance evidence by January 5, 2027
- Company seeking a fifth independent director; no immediate effect on Nasdaq listing while cure period remains available
Item 3.03 · Material Modification to Rights of Security Holders
- Item 3.03 points investors to Item 5.03 for the substantive security-holder rights modification
- Review the charter or bylaw amendment details in Item 5.03 for potential voting, governance, or shareholder-rights impacts
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Restated Charter effective July 9, 2026 after shareholder approval of five governance amendments
- Directors no longer elected by plurality, strengthening majority-vote standards for uncontested elections
- Removal of directors no longer limited to cause, increasing shareholder and board removal flexibility
- Delaware Section 203 opt-out reduces statutory restrictions on potential change-of-control transactions
- Bylaws add majority-vote resignation requirements and tighter advance-notice rules for shareholder nominations and proposals
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 93,987,291 shares represented, establishing a strong quorum against 102,576,943 shares entitled to vote
- All four director nominees elected through the 2027 annual meeting, with 89,910,053–90,426,406 votes supporting
- MaloneBailey, LLP appointment ratified for fiscal 2026 with 93,954,650 votes for
- Stockholders approved charter changes enabling removal of directors without cause and replacing plurality voting requirements
- Stockholders also approved DGCL Section 203 opt-out and officer exculpation, expanding governance flexibility and liability protection
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SBC Medical Group Holdings Inc 8-K filings
Get the next SBC 8-K as it lands
Follow SBC for push alerts, or ask the research agent what this filing means.